Status | Study |
Recruiting |
Study Name: Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009) Condition: Retinoblastoma Date: 2016-08-09 Interventions: Other: Observation no post ope |
Completed |
Study Name: CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma Condition: Retinoblastoma Date: 2014-12-15 Interventions: Drug: carboplatin periocular injection |
Recruiting |
Study Name: Feasibility of Generating Pluripotent Stem Cells From Patients With Familial Retinoblastoma Condition: Retinoblastoma Date: 2014-07-16 Interventions: Other: Skin Biopsy A very smal |
Active, not recruiting |
Study Name: Carboplatin Periocular Injection for Retinoblastoma Condition: Retinoblastoma Date: 2014-05-10 Interventions: Drug: carboplatin periocular injection |
Terminated |
Study Name: Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala Condition: Retinoblastoma Date: 2013-03-25 Interventions: Drug: Temozolomide |
Recruiting |
Study Name: Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma Condition: Retinoblastoma Date: 2013-01-31 Interventions: Drug: vincristine Given via mi |
Terminated |
Study Name: Cancer Biology of Retinoblastoma Condition: Retinoblastoma Date: 2012-07-11 |
Terminated |
Study Name: Intravitreal Injections of Melphalan for Retinoblastoma Condition: Retinoblastoma Date: 2012-03-01 Interventions: Drug: IVit Melphalan IVit injections of Melphalan |
Terminated |
Study Name: A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma Condition: Retinoblastoma Date: 2011-10-19 Interventions: Drug: Intra-Ophthalmic Artery Topotecan Infusion Topotecan via intra-ophthalmic artery delivery infused |
Terminated |
Study Name: Intra-arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma Condition: Retinoblastoma Date: 2011-01-21 Interventions: Drug: Melphalan hydrochloride Drug administered intra-arte |